NYSCI Talks: What is your involvement with CRISPR technology? By Rachel Haurwi


NYSCI (The New York Hall of Science)

Rachel Haurwitz, is the co-founder, President, and CEO of Caribou Biosciences and co-founder of Intellia Therapeutics. She introduces herself as a CRISPR “old timer” as she has been working in the field of gene editing since 2007 and holds patents on multiple CRISPR-based technologies. Haurwitz talks about being part of a group of scientists who are working to bring gene research into the commercial world primarily in the field of developing medicines to fight cancer. She explains how CRISPR which stands for “clustered regular interspaced short palindromic repeats” has democratized gene editing and has game-changing implications for multiple industries and our way of life.


About Author


The New York Hall of Science

The New York Hall of Science, also known as NYSCI, is a science museum located in Flushing Meadows-Corona Park in the New York City borough of Queens. NYSCI was founded at the 1964–65 World’s Fair and has evolved into New York’s center for interactive science, serving a half million students, teachers, and families each year. NYSCI serves schools, families and underserved communities in the New York City area, offering informal, hands-on learning through various products and services that use the “design-make-play” method of bringing delight and play to educating Science, Technology, Engineering and Math (STEM).

Leave A Reply